Skip to content

Study · In vitro (cells) · rat · 2023

2 results

Cortexin® Ameliorates High Glucose-Induced Neuropathy in Cultured Rat Sensory Neurons.

Yazar U, Ayar A

Neuroendocrinology20 Apr 2023Cited by 3 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Efficacy outcome

    In cultured rat sensory neurons, Cortexin concentration-dependently attenuated the high-glucose-induced decrease in Cell Index AUC.

    In plain wordsIn cells from rat sensory neurons, Cortexin increased Cell Index AUC compared with high glucose alone.

    Outcome
    IncreaseCell Index AUC under high glucose
    Study

    ratn: not reported in source

    Primary cultured dorsal root ganglion sensory neurons
    Comparator
    High glucose without Cortexin
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    2-40 µg/mLAs given in this study (rat).

    Measurements

    Cell Index AUC
    0.66 relative units
    high glucose plus Cortexin 40 µg/mL
    Cell Index AUC
    0.18 relative units
    high glucose

    Source sentences

    Summary
    Co-treatment with Cortexin® attenuated this HpG-induced effect, in a concentration-dependent manner (NG: 1.00 ± 0.00 vs. HG: 0.18 ± 0.02, p < 0.05; and HpG + Cortexin® [40 µg/mL]: 0.66 ± 0.17, p = 0.002 versus HpG).
    2 context sentences
    Summary · context
    The aim of this study was to investigate whether Cortexin®, a brain peptide-containing agent, has any mitigating effect on high glucose-induced neuropathy, using primary cultured rat sensory neurons.
    Summary · context
    After allowing for 24 h for cell adhesion and recovery from acute enzymatic trauma, neurons were exposed to high glucose (HpG) in the absence and presence of different concentrations of Cortexin® (2-40 µg/mL).
  2. 02LabIn vitro (cells)Efficacy outcome

    In cultured rat sensory neurons under normoglycemic conditions, Cortexin increased mean Cell Index AUC in a concentration-dependent manner.

    In plain wordsIn cells from rat sensory neurons, Cortexin increased Cell Index AUC under normal glucose conditions compared with no Cortexin.

    Outcome
    IncreaseCell Index AUC under normoglycemia
    Study

    ratn: not reported in source

    Primary cultured dorsal root ganglion sensory neurons
    Comparator
    Normoglycemic conditions without Cortexin
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    2-40 µg/mLAs given in this study (rat).

    Source sentences

    Summary
    In normoglycemic conditions, Cortexin® treatment led to a concentration-dependent increase in the mean AUC values.
    2 context sentences
    Summary · context
    The aim of this study was to investigate whether Cortexin®, a brain peptide-containing agent, has any mitigating effect on high glucose-induced neuropathy, using primary cultured rat sensory neurons.
    Summary · context
    After allowing for 24 h for cell adhesion and recovery from acute enzymatic trauma, neurons were exposed to high glucose (HpG) in the absence and presence of different concentrations of Cortexin® (2-40 µg/mL).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:25 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.